Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RMD · against 1,372 other Healthcare companies
Ranked #563 of 1,373 · scores higher than 59% of peers · safety percentile 59
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)138 peers with a safety percentile of 50–59, including RMD · Click a bar to see the companies
A mix: stronger debt / equity, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.13× | 0.24× | 63% | 33% | |
| BetaLower is better · 1,320 reported | 0.77 | 0.53 | 36% | 33% | |
| Current ratioHigher is better · 1,338 reported | 3.10× | 2.62× | 57% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 559 | 11.2B EUR (≈$12.3B) | 59 | 63 | |
| 560 | 3.5B USD | 59 | 75 | |
| 561 | 3.2B USD | 59 | 65 | |
| 562 | 8.7B CNY (≈$1.2B) | 59 | 77 | |
| 563 | 32.8B USD | 59 | 69 | |
| 564 | 12.6B EUR (≈$13.9B) | 59 | 73 | |
| 565 | 2.91T IDR (≈$180M) | 59 | 50 | |
| 566 | 14.0B CNY (≈$2.0B) | 59 | 40 | |
| 567 | 2.1B CNY (≈$295M) | 59 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score